Právní předpis byl sestaven k datu 04.04.2025.
Zobrazené znění právního předpisu je účinné od 01.04.2025.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
č. 242/2018 Sb. - Čl. II
č. 194/2021 Sb. - Čl. II
č. 159/2022 Sb. - Čl. II
č. 228/2023 Sb. - Čl. II
č. 52/2024 Sb. - Čl. II
č. 176/2024 Sb. - Čl. II
č. 419/2024 Sb. - Čl. II
463
XXXXXXXX VLÁDY
ze dne 18. xxxxxxxx 2013
o xxxxxxxxx návykových látek
Vláda xxxxxxxx xxxxx §44c xxxx. 1 zákona x. 167/1998 Xx., x návykových xxxxxxx x o změně xxxxxxxxx xxxxxxx xxxxxx, xx znění xxxxxx x. 273/2013 Sb.:
§1
Toto xxxxxxxx stanoví
a) x příloze č. 1 k xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Seznamu X xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx1) x
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx jejich zneužívání xxxxx xxxxx, že xxxxxxxxxxxxx nebo xxxxxxx xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx xxx xx xxxxxxx xxxxxxxx x zacházení, xxxx xx x xxxxxx xxxxxx xxxxx zabezpečit, xxx xxxxxx xxxxxxxxx xxxxxxxxxx tyto xxxxxx xxxxx xxxx vydávány x lékárně pouze xx recept nebo xxxxxxx označené xxxxxx xxxxxx směřujícím x xxxxxx xxxxxxx xxxx xx xxxxxxx xxxxxxx xxxx,
(xxxx xxx "seznam x. 1 xxxxxxxx xxxxx"),
x) x příloze č. 2 x tomuto xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx xxxxxx o xxxxxxxx xxxxxxx a
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují xxxxxx, xxxxx zabezpečit, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxx xxxxx xxxx xxxxxxxx v xxxxxxx xx recept xxxx xxxxxxx xxx xxxxxxxx xxxxxx pruhem,
(dále xxx "seznam č. 2 omamných xxxxx"),
x) x příloze č. 3 x xxxxxx xxxxxxxx seznam
1. xxxxxxxx xxxxx xxxxxxxxxx xx Seznamu IV xxxxx Xxxxxxxx xxxxxx x omamných xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, že xxxxxxxxxxxxx nebo xxxxxxx xxxxxxxx xxxxxx, nutné xxxxxxxxxx, xxx látky x přípravky xxxxxxxxxx xxxx xxxxxx xxxxx xxxx xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx terapeutickým xxxxxx xxxxxxxxx v povolení x xxxxxxxxx,
(xxxx jen "xxxxxx x. 3 xxxxxxxx xxxxx"),
x) x příloze č. 4 x xxxxxx xxxxxxxx seznam
1. psychotropních xxxxx xxxxxxxxxx do Xxxxxxx I xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) a
2. dalších xxxxxxxxxxxxxx látek, u xxxxx xx x xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx xxxxx, xx bezprostředně nebo xxxxxxx ohrožují xxxxxx, xxxxx zabezpečit, aby xxxxx a přípravky xxxxxxxxxx xxxx psychotropní xxxxx byly používány xxxxx k xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx omezeným xxxxxxxxxxxxx xxxxxx xxxxxxxxx v xxxxxxxx x zacházení,
(dále xxx "xxxxxx č. 4 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 5 x xxxxxx nařízení xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx II xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx látek, x xxxxx xx x důvodu rozsahu xxxxxx xxxxxxxxxx anebo xxxxx, xx bezprostředně xxxx nepřímo ohrožují xxxxxx, nezbytné umožnit xxxxxxxxx xxx na xxxxxxx xxxxxxxx x xxxxxxxxx, nebo xx x tohoto důvodu xxxxx zabezpečit, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxxxxx xxxxx xxxx xxxxxxxx v xxxxxxx xxxxx xx xxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx rohu xx xxxxxxx xxxxxxx rohu,
(dále xxx "xxxxxx č. 5 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 6 x xxxxxx xxxxxxxx seznam xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XXX xxxxx Xxxxxx o xxxxxxxxxxxxxx xxxxxxx,
x) v příloze č. 7 k tomuto xxxxxxxx seznam
1. xxxxxxxxxxxxxx xxxxx zařazených xx Xxxxxxx XX xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx a
2. xxxxxxx xxxxxxxxxxxxxx látek, x xxxxx xx z xxxxxx rozsahu xxxxxx xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx nebo xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx xxxx látky byly xxxxxxxx x xxxxxxx xx xxxxxx xxxx xxxxxxx xxx označení xxxxxx pruhem,
(dále jen "xxxxxx x. 7 xxxxxxxxxxxxxx látek"), x
x) x příloze č. 8 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxx xxxxxxxxxx xx Xxxxxxx XXX xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx,
(xxxx jen "xxxxxx x. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Xxxx xxxxxxxx xxxx oznámeno x xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx 98/34/ES xx xxx 22. xxxxxx 1998 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx norem x xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro xxxxxx xxxxxxxxxx společnosti, x xxxxxxx xxxxx.
(2) Xxxx xxxxxxxx zapracovává xxxxxxxxx xxxxxxxx Evropské xxxx týkající se xxxxxxxxxx látek3).
§3
Toto xxxxxxxx xxxxxx xxxxxxxxx dnem 1. xxxxx 2014.
Xxxxxxx č. 1 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 1 xxxxxxxx xxxxx
Xxxxxxxxxxx nechráněný xxxxx |
Chemický xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx-6,14-xxxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxxxx-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxx-2-xxxxxxxxxxx)-4-xxxxxxxx]xxxxxxxxx |
|
Xxxxxxxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxx xxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
X-{1-[2-(4-xxxxx-5-xxx-4,5-xxxxxxx-1X-xxxxxxxx-1-xx)xxxxx]-4-(xxxxxxxxxxxxx)xxxxxxxxx-4-xx}-X-xxxxxxxxxxxxxxx |
|
Xxxxxxxxxxx |
3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-1-(4-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxx |
xxxxx-1-[2-(xxxxxxxxx)xxxxx]-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
2,2-xxxxxxx-4-[4-(2-xxx-3-xxxxxxxxx-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx)xxxxxxxxxx]xxxxxxxxxxx |
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxx-1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
(5X,6X,7X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
Xxxxxxx |
xxxxxxxx (x.X.2X,3X5X)3-xxxxxxx-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, xxxx xxxxxx x xxxxxxxx, x xxxxxxx xx xxxxx získat xxxxxxx x xxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X,1-xxxxxxxx-3,3-xxx(2-xxxxxxx)-2-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
1-[2-(xxxxxxxxxxxx)xxxxx]-2-(4-xxxxxxxxxxxx)-5-xxxxx-1X-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(2-xxxxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxx x xxxxxx xxx léčebné xxxxxxx |
Xxxxxxx z xxxxxx xxxxxxxx k přípravě xxxxxxxx xxxxxxxxx se xxxxxxxxxxxxxxxx obsahem xxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
X-(1-xxxxxx-2-xxxxxxxxxxxxxxx)xxxxxxxxxxxx |
|
Xxxxxxxxx |
(2XX,6X,11X)-3-xxxxxxxx-6,11-xxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
|
Xxxxxxxxxx |
17-xxxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xxxxxx)xxxxx]xxx}xxxxxx |
|
Xxxx - xxxx |
Xxxxxx xxxx |
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxx |
|
Xxxxxxxxxx z xxxxxxxx |
Xxxxxxxxxxx x xxxxxx alkaloidů xxxxxxx xxxxxxxxxxxxxx xxxxxxx xxxxxxxx |
|
Xxxxxx xxxxxxx a xxxxxxxx |
X výjimkou xxxxx xxxxxx extrakt a xxxxxxxx, xxxxx obsahuje 1 % xxxxx xx skupiny xxxxxxxxxxxxxxxxxxxx x xxxxxxx podmínku xxxxxxxxxxx xxxxx xxxxxx x xxxxxx xxxxxxxxxxx xxxxxxx |
|
Xxxxxx pro xxxxxxx xxxxxxx |
||
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx dextromethorfan [(+)-3-xxxxxxx-17-xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx |
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx xxxxxxxxxxxx [(+)-3-xxxxxxx-17-xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx v této xxxxxxx |
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3-xxxxxxxxx-8-xx |
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxx, xxxxxxxxxxx |
4-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
4,5α-xxxxx-6,17-xxxxxxxxxxxxxx-6-xx-3-xx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5-xxxxx-6,17-xxxxxxxxxxxxxxxx-3,6-xxxx |
|
Xxxxxxx |
4,5-xxxxx-3-xxxxxxx-5,17-xxxxxxxxxxxxxxxx-6-xx |
|
Xxxxxxx, xxxxxxxxxxx |
2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxx xxxxxxxx |
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
Xxxxxxxxxxx xxxxxx xxx léčebné použití |
základně xxxxxxxxxx xxxxxxxx konopí xxx xxxxxxx xxxxxxx xxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(2-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx |
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x xxxx xxxxxxxx xxxxxxx xx xxxxxxxxxx dusíkem xxxxxx derivátů xxxxxx-X-xxxxx |
Xxxxxx-X-xxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
Xxxxxxxxxxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxx |
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
Xxxxx |
Xxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, xxxxxxx stupeň xxxxxx je vyšší xxx D4 nebo XX2 |
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxxxxx 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
Xxxxxxxxx |
xxxxx-1-(3-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
1'-(3,3-xxxxxxx-3-xxxxxxxxxx)-4'-xxxxxx-1,4'-xxxxxxxxxxx |
|
Xxxxxxxxxxx |
4-xxxxx-1,3-xxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
xxxxxxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxxx |
(9XX,13XX,14XX)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
|
Xxxxxxxxxxx |
(3XX)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
Xxxxxxxxxx |
(9XX,13XX,14XX)-17-xxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxx |
xxxxxx-3-[4-(X-xxxxxxxxxxxxxxx)-4-(xxxxxxxxxxxxxxx)]xxxxxxxxxx]xxxxxxxxx |
|
Xxxxxxxxxx |
X-{4-(xxxxxxxxxxxxx)-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxxxxx |
3-[(1X,2X)-3-(xxxxxxxxxxxxx)-1-xxxxx-2-xxxxxxxxxxxx]xxxxx |
|
Xxxxxxx |
4,5α-xxxxx-3,6-xxxxxxxxx-17-xxxxxxxxxxxxx-6,8-xxxx |
|
Xxxxxxxx |
(5X)-4,5-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-6-xx-6-xx-xxxxxx |
|
Xxxxxxxxxxxx | xxxxxx 4-(N-(2-methoxyacetyl)anilin)-1-(2-thiofen-2-ylethyl)piperidin-4-karboxylát | A-3080, Xxxxxxx |
Xxxxxxxxxxxx |
X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxx |
xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
(XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx uvedených v xxxxx xxxxxxx, xxxx xxxxxx x ethery xxxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu x solí xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxxxx xxxx xxxxxxx, xxxxxx x xxxxx xx xxxxx xxxxxxxxx, xxx xxxx soli xxxxx xxxxxxxxx.
Příloha x. 2 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 2 omamných xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxx xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, včetně xxxx xxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx xx xxxxx případech, xxx xxxx soli xxxxx existovat.
Xxxxxxx x. 3 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 3 xxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x&xxxx;xxxxxx xxxxxx / xxxxxx xxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx obecný xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-(1-xxxxxx-xxxxxxxxx-4-xx)-xxxxxxxx |
XXX 73750 |
Acetylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]acetamid |
||
Acryloylfentanyl |
Acrylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]prop-2-enamid |
|
AH-7921 |
3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid |
||
AP-237 |
bucinnazin; 1-X-xxxxxxx-4- xxxxxxxxxxxxxxxxxx; |
1-[4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xx]xxxxx-1-xx |
|
XX-238 |
1-[2,6-xxxxxxxx-4-(3-xxxxxxxxx-2-xxxx)xxxxxxxxx-1-xx]xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxxxx |
XXX-X; benzodioxole-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl-1-2H-1,3-benzodioxol-5-karboxamid |
|
Benzoylbenzylfentanyl |
N-fenyl-N-(1-benzyl-piperidin-4-yl)benzamid |
||
Benzoylfentanyl |
fenylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]benzamid |
|
Benzylfentanyl |
Benzyl-F; X4129 |
X-xxxxx-X-[1 -(xxxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxx XxX |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxx-2-xxxxxxxxxx |
|
Xxxxxxxxxx |
X 4793e; X 47931X |
4-xxxx-X-(2-(xxxxxxxxxxxxx) xxxxxxxxxx) xxxxxxxx |
|
Xxxxxxx |
Xxxxxxxxx |
3-{1-[1-(4-xxxxxxxxx)xxxxx]xxxxxxxxx-4-xx}-1X-xxxxxxxxxxxx-2-xx |
|
Xxxxxxxxxxx |
2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-5-xxxxx-xX-xxxxxxxxxxxx-1-xxxxxxxxx |
||
4-Xxxxxxxxxxxxxxxxxxxxx |
4-Xx-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxx-X; XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxxx |
X530 |
4-(4-xxxxxxxxxx)-2,2-xxxxxxx-1-(1-xxxxxxxxxxxx)-1-xxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
||
Xxxxxxxxxxxx-2-xxxxx xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
Xxxxxxxxxxxx-4-xxxxx xxxxxxxx |
X-(4-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
Xxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxx-1-xx)xxxxxx-3-xx |
||
Xxxxxx |
xxxxxxxxxxxxxx |
2-[2-[(4-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]-X,X-xxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxx |
2-{2-[(2,3-xxxxxxx-1-xxxxxxxxxx-5-xx)xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xx}-X,X- diethylethan-1-amin |
||
Etometazen |
5-methyl etodesnitazen; 5-methyl xxxxxxxxxxxxxxxxxx |
2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-5-xxxxxx-1X-xxxxxxxxxxxx-1-xxxxxxxxx |
|
Xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxxxxxxxx |
2-(4-xxxxxxxxxxxx)-5-xxxxx-1-(2-(xxxxxxxxx-1-xx)xxxxx)-1X-xxxxx[x]xxxxxxxx |
|
Xxxxxxxxxxxx |
2-[(4-xxxxxxxxxxx)xxxxxx]-5-xxxxx-1-(2-xxxxxxxxxx-1-xxxxxxx)-1X-xxxxxxxxxxxxx |
||
Xxxxxxx |
(5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
||
Xxxxxxxx xxxxxxxxx analog |
butyrfentanyl |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]-butanamid |
|
3 -Xxxxxxxxxxxxxxxxxxxxx |
β'-xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-x]-3-xxxxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxxxxxxx |
Xxxxxxxxxx |
X,X-xxxxxxx-2-{2-[(4-xxxxxxxxxx)xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xx}xxxxxxxxx |
||
2’-Xxxxx-2-xxxxx-3-xxxxxxxxxxxxxx |
X-(1-(2-xxxxxxxxxxxxx)-3-xxxxxxxxxxxxxxx-4-xx)-X-(2-xxxxxxxxxx)xxxxxxxxxxx |
||
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx |
|
4-Xxxxx-xxxxxxxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxxxx- xxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxx-4-xx)-xxxxxxxxxxxxxxxxxxxxx |
|
2-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
2-XX, x-XX |
3-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(3-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, x-XX |
4-Xxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxx; 4X-xxxxxxxxxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxxxx-4-xx)xxxxx-2-xxxxxxxxxx |
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4X-1XX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
3-XxxxxxxxxxxxxxxxxXxxxxxxxx |
xxxxx-xxxxxxxxxxxxxxxxxx- fentanyl |
N-(3-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid |
|
2F-viminol |
2-[di(butan-2-yl)amino]-1-[1-(2-fluorbenzyl)-1N-pyrrol-2-yl]ethan-1-ol |
||
Furanyl XX-17 |
X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxx-xxxxx-2-xxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
XX-X; 2-xxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxx-2-xxxxxxxxxx |
|
(xxx)Xxxxxxx-X-xxxxxxxx X-xxxxxx xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx |
||
Xxxxxx |
(5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx |
||
4-xxxxxxxxxxxxxxxxxxxx |
4-XX-XX; x-xxxxxxxxxxxxxx xxxxxxxx |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxxxxxx |
|
Xxxxxxxxxxxxxxxx |
2-xxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxx |
||
Xxxxxxxxx-X-47700 |
3,4-xxxxxxxX-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-(xxxxxx-2-xx)xxxxxxxx |
||
Xxxxxxxxxxxx |
X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xxxxx xxxx |
||
Xxxxxxxx-xxxxxxxx |
(4-xxxxxxxxx)-(1-(xxxxxxxxxxxxx)-4-xxxxxxx-4-xxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
Xxxxxxxxxxx |
1-[4-(3-xxxxxxx xxxxx)-1 -xxxxxxxxxxxxxxx-4-xx]xxxxxx-1-xx |
||
Xxxxxx |
X xxxxxxxx konopí xxx xxxxxxx xxxxxxx uvedené x seznamu č. 1 |
||
Krotonylfentanyl |
(2E)-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2-butenamid |
||
Methoxyacetylfentanyl |
Methoxy-AcF |
2-methoxy-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid |
|
4-Methoxybutyrfentanyl |
4-MeO-BF |
N-(4-methoxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]butanamid |
|
2-Methylacetylfentanyl |
o-methylacetylfentanyl |
N-(2-methylfenyl)-N-[1-(2-fenylethyl)-piperidin-4-yl]-acetamid |
|
2-Methyl-AP-237 |
2-methyl-bucinnazin |
1-[2-methyl-4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on |
|
3,4-Methylendioxy-U-47700 |
3,4-MDO-U-47700; 3,4-MDU-47700; XXX-47; XXX-47700 |
X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxx[x][1,3]xxxxxx-5-xxxxxxxxxx |
|
α-Xxxxxxxxxxxxxx xxxxxxxxx analog |
BF; X-X |
2-xxxxxx-X-xxxxx-X-[1-(1-xxxxxxxxxxx-2-xx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
3 -XxxxxXxxxxxxxXxxxxxxxx |
β'-xxxxxXxxxxxxxXxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-3-xxxxxxxxx-2-xxxxxx |
|
Xxxxxxxxxxxxxx |
X,X-xxxxxxx-2-[2-[(4-xxxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]xxxxxxxxx |
||
Xxxxxxxxxxx |
X,X-xxxxxxx-2-[2-[(4-xxxxxxxxxxxx)xxxxxx]-5-xxxxxxxxxxxxxxxxx-1-xx]xxxxxxxxx |
||
Xxxxxxxxxxxxx |
2-(4-xxxxxxxxxxxxx)-5-xxxxx-1-(2-(xxxxxxxxxx-1-xx)xxxxx)-1X-xxxxx[x]xxxxxxxx |
||
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
||
X-xxxxxxxxxxxxxxxxxx |
2-[2-[(4-xxxxxxxxxxx)xxxxxx]-5-xxxxx-xxxxxxxxxxxx-1-xx]-X-xxxxx-xxxxxxxxx |
||
X-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-2-[2-[(4-xxxxxxxxxxxxxxx)xxxxxx]-5-xxxxx-xxxxxxxxxxxx-1-xx]xxxxxxxxx |
||
X-xxxxxx U-47931E |
N-methylbromadolin |
4-brom-N-(2-(dimethylamino)cyklohexyl)-N-methylbenzamid |
|
Nortilidin |
ethyl 2-xxxxxxxxxxx-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
||
X-XXXX; xxxxxxxxxxxxxxxxxxxxxxxx |
3-(4-xxxxxx-1-xxxxxxxxxxxxxxx-4-xx)xxxxx xxxxxx |
||
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxxxxx, PBN, 127X49 |
1-(4,4-xx(xxxxxxx-2-xx)xxx-3-xx-2-xx)xxxxxxxxx |
|
Xxxxxxxxxxxx |
X,X-xxxxxxx-5-xxxxx-2-[(4-xxxxxxxxxxxx)xxxxxx]-1-X-xxxxxxxxxxxx-1-xxxxxxxxx |
||
Xxxxxxxxxxxxxx |
5-xxxxx-2-[(4-xxxxxxxxxxxxx)xxxxxx]-1-(2-xxxxxxxxxx-1-xxxxxxx)xxxxxxxxxxxxx |
||
Xxxxxxxxxx z konopí |
|||
Tetrahydrofuranfentanyl |
THF-F |
N-(1-fenylethylpiperidin-4-yl)-N-fenyltetrahydrofuran-2-karboxamid |
|
Tetramethylcyklopropanfentanyl |
TMCP-fentanyl; XXXX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-1- xxxxxxxxxx |
|
Xxxxxxxxxxxxxxx |
2-xxxxxxxxxxx xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxxxxxxxx |
|
4-(Xxxxxxxxxxxxxx) X-47700 |
X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxx-4-(xxxxxxxxxxxxxx)xxxxxxxx |
||
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-48800 |
2-(2,4-xxxxxxxxxxxx)-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
||
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-50488 |
3,4-xxxxxxx-X-xxxxxx-X-[2-(1-xxxxxxxxxxxx)xxxxxxxxxx] xxxxxxxxxxxxxx |
||
X-51754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
XxxxxxXxxxxxxxx |
XXX, XX |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; fentanyl xxxxxxxxxx analog |
Včetně xxxx xxxxxxxx xxxxx uvedených x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx č. 4 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 4 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx nechráněný xxxxx (XXX) |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx obecný xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
1-(Xxxxxxxxxxxxxxxx)-2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-1X-xxxxxxxxxxxx-5-xxxxxxxxxx |
|||
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
1-(2-(Xxxxxxxxxxx)xxxxxxxxx)xxxxxxxx |
XXXXX |
2-(xxxxxxxxxxx)-1-(xxxxxxxx-1-xx)xxxxxx-1-xx |
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
1-Xxxxxxx |
1-xxxxxxxxx |
1-xxxxxxxx-1-xx-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
1x-XXX, 1X-XXX |
xxxxxxxxxxx xxxxxxxx 1-xxxxxxxxx xxxxxxxxx; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx- -6,6a,8,9-tetrahydroindol[4,3-fg]chinolin-9-karboxamid |
||
2,3-Dimethylmetkathinon |
2,3-DMMC |
1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on |
|
2,3-Methylendioxymethkathinon |
2,3-MDMC |
1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on |
|
2,4,5-Trimethylmethkathinon |
2,4,5-TMMC |
||
2,4,6-Trimethoxyamfetamin |
TMA-6 |
1-(2,4,6-trimethoxyfenyl)propan-2-amin |
|
2,4-Dimethylethkathinon |
2,4-DMEC |
1-(2,4-dimethylfenyl)-2-(ethylamino)propan-1-on |
|
2,4-Dimethylmetkathinon |
2,4-DMMC |
1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
2',4'-Dimethyl-α-pyrrolidinpropiofenon |
2,4-DMPPP |
1-(2,4-dimethylfenyl)-2-pyrrolidin-1-yl-propan-1-on |
|
2,5-Dimethoxy-4-chloramfetamin |
DOC |
1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin |
|
2,5-Dimethoxy-4-jodamfetamin |
DOI |
1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin |
|
25B-NBOMe |
2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
Cimbi-36 |
|
25C-NBOMe |
2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
2C-C-NBOMe |
|
25I-NBF; 25X-XX2X; 2X-X-XXX, XXX-2X-X; Xxxxx-21 |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X[(2-xxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
25X-XXXX |
2-{[2-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxx |
2X-X-XXXX; Xxxxx-27 |
|
251-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2X-X-XXX |
2X-X-XXX |
2-(4-xxxx-2,3,6,7-xxxxxxxxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxxxxx |
|
2X-X |
2X-X |
2,5-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxx |
XX-25 |
2X-X |
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-2-xxxxxxxxxxx-1-(2-xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxxxxx |
2-Xx-2'-Xxx-XXX, |
2-(2-xxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX; 2-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2X-XXXXX; XXX-13 |
8-xxxxxxxxxx-3-[(4,4-xxxxxxφxxxxxxxx-1-xx)xxxxxxxx]-4-xxxxxxxxxxxxx |
||
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2-XXXX |
1-(xxxxxxxxxx-2-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
2-Xxxxxxxxxxxxxxx |
X-xxxxxx-xx-XXXX-2 |
1-(6-xxxxxxx-1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
2-XXXX |
1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
2-XXXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)-xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxxx |
2-XXX |
(2XX)-1-[2-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
2-Xxxxxxxxxx-3-xxxxxxx-xxxxxxxxxxx |
α-XXX-XxX; XXxXXX |
3-xxxxxxx-1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
3-(4-Xxxxxxxxxxxxxxxxxxxx)-1-xxxxxxxxxxx |
Xxx Xxxx |
[4-(xxxxxxxxxxxxx)xxxxx]-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
|
3-(x-Xxxxxxxxxxxxxx)-X-xxxxxxxxxxx |
(4-xxxxxxxxxxxx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
3',4'- Xxxxxxxxxxxxx-α-xxxxxx PPP |
MDMPP |
1-(3,4-methylendioxyfenyl)-2-methyl-2-pyrrolidinylpropan-1-on |
|
3,4-Dichlorethkathinon |
3,4-DCEC; |
1-(3,4-dichlorfenyl)-2-(ethylamino)propan-1-on |
|
3,4-Dichlormethylfenidát |
3,4-CTMP |
methyl (2R)-2-(3,4-dichlorfenyl)-2-[(2R)-pipendin-2-yl]acetát |
|
3,4-Dichlor-N,N-cyklohexylmethylmeth-kathinon |
3,4-DCCHMMC |
2-(cyklohexylmethylamino)-1-(3,4-dichlorfenyl)propan-1-on |
|
3,4-Dimethoxy-α-PHP |
3,4-DMeO-α-PHP |
1-(3,4-dimethoxyfenyl)-2-(pyrrolidin-1-yl)hexan-1-on |
|
3,4-Dimethylethkathinon |
3,4-DMEC |
1-(3,4-dimethylfenyl)-2-(ethylamino)propan-1-on |
|
3,4-Dimethylmetkathinon |
3,4-DMMC |
1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
3,4-Dimethyoxy-α-pyrrolidinovalerofenon |
3,4-DMeO-α-PVP |
1-(3,4-dimethoxyfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
3,4-Methylendioxypyrovaleron |
MDPV |
1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on |
MDPK |
3',4'-Methylendioxy-α-pyrrolidinbutyro-fenon |
MDPBP |
(RS)-1-(3,4-methylendioxyfenyl)-2-(1-pyrrolidinyl)butan-1-on |
|
3 ',4'-Xxxxxxxxxxxxx-α-XXX |
XXXXX |
1-(3,4-xxxxxxxxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
3 -Xxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-2-xxxxxxxxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|
3X-Xxxxxxxxxxx |
3-XXX; XXX-593 |
2-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX; 3-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-2-xxxx; X-xxxxx-3-xxxxxxxxxxxxxx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxx-α-XXX |
3X-α-XXX; 3X-XXX |
1-(3-xxxxxxxxxx)-2-(1-xxxxxxxxxx)xxxxxx-1-xx |
3-Xxxxx-α-XXX |
3-Xxxxxxxxxxxxxxxx |
3-XXX, XXXX, 3-oxyfenazepam, 3 -xx droxy xxxxxxxxx |
7-xxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XX-XXX; |
3-[1-(xxxxxxxxx-1-xx)xxxxxxxxxx] xxxxx |
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
3-Xxxxxxx xxxxxxxxxxx |
3-XxX-XXX |
X-xxxxx-1-(3-xxxxxxxxxxxx)xxxxxxxxxx-1-xxxx |
|
3-Xxxxxxx fencyklidin |
3-MeO-PCP |
1-[1-(3-methoxyfenyl)cyklohexyl]piperidin |
|
3-Methoxymethkathinon |
3-MeOMC |
1-(3-methoxyfenyl)-2-(methylamino)propan-1-on |
|
3-Methyl-4-fluormethkathinon |
3-Methylflefedron |
1-(4-fluor-3-methylfenyl)-2-(methylamino)propan-1-on |
|
3-Methylamfetamin |
3-MA |
(2RS)-1-(3-methylfenyl)propan-2-amin |
|
3-Methylethkathinon |
3-MEC |
2-(ethylamino)-1-(3-methylfenyl)propan-1-on |
|
3-Methylmetamfetamin |
3-MMA |
1-(3-methylfenyl)-N-methylpropan-2-amin |
|
3-Methylmetkathinon |
3-MMC |
2-(methylamino)-1-(3-methylfenyl)propan-1-on |
|
3-Methyl-N,N-dimethylkathinon |
3-MDMC |
1-(3-methylfenyl)-2-(dimethylamino)propan-1-on |
|
3-Methyl-N-ethylnorpentedron |
3-MEAP |
2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on |
|
3-Methylthioamfetamin |
3-MTA |
(2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin |
|
4'-Fluor-4-methylaminorex |
4-FPO; x-X-4-xxxxxxxxxxxxxx |
5-(4-xxxxxxxxxx)-4,5-xxxxxxx-4-xxxxxx-2-xxxxxxxxxx |
|
4'-Xxxxxx-X-xxxxxxxxxxxxxxxxxx |
4'-xxxxxx-XxXX |
1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxx-1-xx)xxxxx-1-xx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx |
4'-xxxxxx-α-XxXX |
4-xxxxxx-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4'-xxxxxx-α-XXX; XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
4'-Xxxxx-α-XXX |
4'-xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
|
4-Xxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
4-Xxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4Xx-α-XXX |
1-(4-xxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
4-Xxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4Xx-α-XXX; xXXXX, 4Xx-XXX |
1-(4-xxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-2-xxxxxxxxxxx-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
4X-Xxxxxxxxxxx |
4-XXX |
2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
||
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4X-XXX; p-fluoroethylphenidate |
ethyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát |
|
4-Fluorkathinon |
4-FC |
2-amino-1-(4-fluorfenyl)-propan-1-on |
|
4-Fluormethamfetamin |
4-FMA |
(RS)-1-(4-fluorfenyl)-N-methylpropan-2-amin |
|
4-Fluormethkathinon |
4-FMC |
1-(4-fluorfenyl)-2-(methylamino)propan-1-on |
Flefedron |
4F-MPH; 4-XXXX |
Xxxxxx-2-(4-xxxxxxxxxx)-2-(2-xxxxxxxx)xxxxxx |
4X-XXX |
|
4-Xxxxx-X-xxxxxxxxxxxxx |
4X-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxx-1-xx |
|
4-Xxxxx-X-xxxxxxxxxxxxxx |
4X-XXX; 4-xxxxx-α-xxxxxxxxxx-xxxxxxxxxxx |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-X-xxxxxxxxxxxxxxxxxxxxx |
4X-XXX; 4X-XXX; 4F-NIPP |
1-(4-fluorfenyl)-2-(1-methylethylamino)pentan-1-on |
|
4-Fluorpentedron |
4-FPD; 4-X-xxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxxx-α-XXX; 4X-XXX; X-2370 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxx |
4X-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4X-α-XXX; 4X-XX8 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-X-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx |
4X-xxxxx-XXxX; 4X-α-XxXX |
1-(4-xxxxxxxxxx)-4-xxxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4X-α-XXX; 4X-XX9 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4X-XXXX-XXXX |
xxxxxx (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
4X-XXXX-XXXXXX; 4X-XXX |
xxxxxx (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
4-X-α-XXX xxxxxxxxx xxxxxx |
1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxx)xxxxxx-1-xx |
||
4-XXXXXXX |
4-xxxxxxx-3,3,4-xxxxxxxxx-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxx-1-xx |
||
4-Xxxxxxx-X-xxxxxx-X-xxxxx tryptamin |
4-HO-MET |
3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol |
Metocin; Xxxxxxxxxxx |
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
4-XX-XxXX |
3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxxx |
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-Xx-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
4-Xxxxxxxxxxxxx |
Xx5-4864, xxxxxxxxxxxxxx |
7-xxxxx-5-(4-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxxxxxx |
4-XXX; xxxxxxxxxxx, |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX \ |
4-Chlormethkathinon |
4-CMC |
1-(4-chlorfenyl)-2-(methylamino)propan-1-on |
Clefedron |
4-Chlor-N,N-dimethylkathinon |
4-CDC; 4-XXXX |
1-(4-xxxxxxxxxx)-2-(X,X-xxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-X-xxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
4-Xxxxxxxxxxxxxxxxxx |
4-Xxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxx-α-XXX |
1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
4-XXXX |
4-XXXX |
1-(xxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX; 4-XXXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX; 4-XxX-α-XX8 |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxxxx α-XXX; 4-XxX-α-XX9 |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4'-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4'-Xxxxxxx-α-XXX; XXXXX |
(XX)-1-(4-xxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
4-XX |
|||
4-Xxxxxxxxxxxxxx |
4-Xx-XXXX |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxx |
Xxxxxxxxxxx; 4-XX |
2-xxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxx |
2-xxxxxxxxxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-xxxxxx-X-xxxxxxxxxxxxxx |
(4-XXX) |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxx-1-xx |
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
5 - Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
5-XXXx; xxxxxxx-α-XXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
5X-XXX48; 5X-XXXXXXX |
X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
5Xx-XX-XXXXXX |
X-[(2X)-1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx]-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
5Xx-XXXX-XXXXXX; 5Cl-ADB |
methyl 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
5-Xx-xxxxxx XXX 018 xxxxxxx xxxxxx |
5Xx-XXX-018; 5Cl-JWH-018-N, THJ-018 xxxxxx xxxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
|
5 -Xxxxxxxxxxxxxxxxxxxxxxxxxxxx |
5-XXXXX; XXXX |
1-(2,3-xxxxxxxxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
5X-3,5-XX-XXXXXXXX; 5X-3,5-XX-XXXXXXX, XX-037 |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-3-(4-xxxxxxxxxx)-1X-xxxxxxx-5-xxxxxxxxxx |
||
5X-5,3-XX-XXXXXXXX; 5X-XX-XXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-5-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XX-X7XXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
5X-XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX57 |
xxxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXX |
xxxxxx (2X)-2-[[1-(5-xxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxxxxxxxxxx |
||
5X-XXX-XXXXXX; 5X-XXX |
xxxxxx-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
5X-XXX |
|
5X-X-X7XXXX |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXX |
X-(1-xxxxx-1-xxx-3-xxxxxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
5X-XXXXX-XXXXXXXXX |
5-(5-xxxxxxxxxxx)-2-(1-xxxxxx-1-xxxxxxxxxx)-xxxxxx[4,3-x]xxxxx-1-xx |
||
5X-XXXX-XXXXXX |
xxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
5X-XXX-XXXXXX |
xxxxx 2-[[1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx |
||
5X-XXX-398; XX-2201; |
(4-chlornaftalen-1-yl)[1-(5-fluorpentyl)-1H-indol-3-yl]-methanon |
||
5F-MDMB-P7AICA |
methyl-2-{[1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]formamido}-3,3-dimethyl xxxxxxxx |
||
5X-XXXX-XXXX; |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
5X-XXXX-XXXXXX; 5X-XXX |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
5X-XXXX-2 |
1-(5-xxxxxxxxxxx)-X-(xxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XX-22 xxxxxxx xxxxxx |
xxxxxxxx-8-xx 1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XX-22; 5F-QUPIC |
8-chinolinyl ester xxxxxxxx 1-(5-fluorpentyl)-1H-indol-3-karboxylové |
||
5-F-pentyl-3-pyridinoylindol |
[1-(5-fluorpentyl)-1H-indol-3-yl] (xxxxxxx-3-xx)xxxxxxxx |
||
5X-XX-XXXX |
1-(5-xxxxxxxxxxx)-3-(xxxxxxxxxx-1-xxxxxxxx)-1-X-xxxxx |
||
5X-XX-XXXXXX |
[1-(5-xxxxxxxxxxx)xxxxxxx-3-xx]-xxxxxxxxxx-1-xx-xxxxxxxx |
||
5X-XXX-005 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX-006 |
X-xxxxxx-1-(5-xxxxxxxxxxx)-x X-xxxxx-3-xxxxxxxxxx |
||
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXX-11 |
|
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
5-XxX-XXX |
5 -methoxy-α-methyltryptamin |
||
5-MeO-DALT |
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amin |
||
5-MeO-MiPT |
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amin; 5-xxxxxxx-X-xxxxxx-X-xxx-xxxxxx xxxxxxxxx |
||
5-Xxxxxxxxxxxx Xxx |
X-xxxxxx-xx-XXXX-5 |
1-(7-xxxxxxxxxxxx[x] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
5-XXXx |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
6-XXX |
6-(2-xxxxxxxxxxx)xxxxxxxxxx |
||
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
X-796,260 |
[1-(2-xxxxxxxx-4-xxxxxxx)-1X-xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
X-796,260 xxxxxx |
((X)-1-(1-(2-xxxxxxx-1-xx)xxxxx)xxxxx-3-xx)-3,4,4-xxxxxxxxxxxx-2-xx-1-xx |
||
X-834,735 |
1-(xxxxxxxxxxxxxxx-4-xxxxxxxx)-1X-xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
X-836,339 |
X-[3-(2-xxxxxxxxxxxx)-4,5-xxxxxxxx-1,3-xxxxxxx-2-xxxxxx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-xxxxxxxxxx |
||
XX-005 |
[1-[(1-xxxxxx-2-xxxxxxxxxxx)xxxxxx]-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)-xxxxxxxx |
||
XX-005 xxxxxx xxxxxx |
(1-(1-xxxxxxxxxxxx-2-xx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-[(2-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXXXXXX; |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-3-(4-xxxxxxxxxx)-1X-xxxxxxx-5-xxxxxxxxxx |
||
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-x(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(2-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxx-XXXXXXXX |
X-(1-xxxxxxxxx)-1-(xxxxxxx xxxxxxxx-4-xxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxx-xxxx |
||
XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-\X- indazol-3-karboxamid |
||
Adinazolam |
U 41123 |
1-(8-chlor-6-fenyl-4H-[1,2,4]tnazolo[4,5-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethan xxxx |
|
X-XXXXXXXX |
X-(1-xxxxxxxxx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-57 |
Xxxxxxx-1-xx-1-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
XX-XXX |
(6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxx-9-xxxxxxxxxx |
6-xxxxx-6-xxx-XXX |
|
Xxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxx |
(2-(3-(xxxxxxxxxxx)-5-xxxxxx-4-X-1,2,4-xxxxxxx-4-xx)-5-xxxxxxxxxx)(xxxxx)xxxxxxxx |
||
XX-1220 |
1-[(1-xxxxxxxxxxxxxxx-2-xx)xxxxxx]-1X-xxxxx-3-xx}(xxxxxx)-xxxxxxxx |
||
XX-1220 xxxxxx xxxxxx |
1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx] (xxxxxx)xxxxxxxx |
||
XX-1248 |
xxxxxxx-1-xx(1-((1-xxxxxxxxxxxxxxx-2-xx)xxxxxx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XX-1248 xxxxxx xxxxxx |
xxxxxxx-1-xx(1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
XX-2201 xxxxxxxxxxxx xxxxxx; XXXXXXXX |
(1-(5-xxxxxxxxxxx)-1X-xxxxx[x]xxxxxxxx-2-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XX-2201 xxxxxxx xxxxxxxxxx xxxxxx |
X-1-xxxxxxxxxx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-2232 |
5-[3-(1-xxxxxxx)-1X-xxxxx-1-xx]xxxxxxxxxxxx |
||
XX-2233 |
1-[(X-xxxxxxxxxxxxxxx-2-xx)xxxxxx]-3-(2-xxxxxxxxxx)xxxxx |
||
XX-6527 |
1-xxxxxx-X-(xxxxxxxx-1-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XX-6527 5-xxxxxxxxxxx xxxxxxx |
1-(5-xxxxxxxxxxx)-X-(xxxxxxxx-1-xx)-1X-xxxxx-3-xxxxxxxxx |
||
XX-679 |
(2-xxxxxxxx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XX-694 |
1-[(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(2-xxxxxxxx)xxxxxxxx |
||
XX-694 (xxxxx xxxxxxxxx xxx) |
1-(5-xxxxxxxxxxx)-3-(2-xxxxxxxxxxxx)xxxxx |
||
XX-694 (xxxxxx xxxxxxxxx iod) |
1-(5-fluorpentyl)-3-(2-methylbenzoyl)indol |
||
AM-694 xxxxx xxxxxxx |
1-[(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(2-xxxxxxxx)xxxxxxxx |
||
XXX-4xx-XXXX |
xxxxxx-3-xxxxxx-2-[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xxxxxxxxxxx]xxxxxxxx |
||
XXX-XXXXXX |
xxxxxx 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xxxxxxxxxx]-3-xxxxxxxxxxxxxx |
||
XXX-XXXXXXXX; FUB-AMB |
Methyl 2-({1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
XXX-XXXXXXXX |
|
XXX-XXXXXX |
Xxxxxx (2S)-2-{[1-(cyklohexylmethyl)indol-3-karbonyl]amino}-3-methylbutanoát |
||
AMB-CHMrNACA |
methyl 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamid)-3-methylbutanoát |
||
APICA; XXX-001, 2XX1 |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
XXX48 |
|
XXX-XXXXXX |
X-(1-xxxxx-1-xxx-3-xxxxxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-(xxxxxxxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
xx-2X-X; βx-2X-X |
2-xxxxx-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xx |
||
xx-XXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
||
xx-XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
||
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxx-1-xx |
||
XXXX; 3,4-XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxx |
8-xxxx-6-xxxxx-1-xxxxxx-4X-xxxxx[x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
||
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
Xxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx |
|
XXX-018 |
xxxxxxxx-1-xx 1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XX 47,497 |
2-[(1S,3R)-3-hydroxycyklohexyll-5-(2-methyloktan-2-yl)fenol |
||
CP 47,497 (X8 + X2) |
2-((1X,3X)-3-xxxxxxxxxxxxxxxxx)-5-(2-xxxxxxxxxxx-2-xx)xxxxx; 2-((1X,3X)-3-xxxxxxxxxxxxxxxxx)-5-(xxxxx-3-xx)-xxxxx |
1,1-xxxxxxxx x 1-xxxxx xxxxxxx C8-homologu |
|
CRA-13 |
(naftalen-1-yl)[4-(pentyloxy)naftalen-1-yl]methanon |
CB-13 |
|
CUMYL-4CN-B7AICA |
1-(4-kyanobutyl)-N-(2-fenylpropan-2-yl)-1H-pyrrol[2,3-b]pyridin-3-karboxamid |
||
CUMYL-4CN-BINACA; XXX-78 |
1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-5X-X7XXXX |
1-(5-x:xxxφxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-5XXXXX |
1-(5-xxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXX-5XXXXXXX |
|||
XXXXX-XXXX |
1-xxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXX-XX-XXXXXXXXX |
5-(xxxxxxxxxxxxxxxx)-2-(1-xxxxxx-1-xxxxx-xxxxx)xxxxxx[4,3-x]xxxxx-1-xx |
||
XXXXX-XXXXXXXXX; XXX-151 |
2-(1-xxxxxx-1-xxxxxxxxxx)-5-xxxxxx-xxxxxx[4,3-x]xxxxx-1-xx |
||
XXXXX-XXXX |
1-xxxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXX-XXXXXX |
1-xxxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-XXXXXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1-((xxxxxxxxxx-2X-xxxxx-4-xx)xxxxxx)-1-X-xxxxxxx-3-xxxxxxxxxx |
||
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxxx |
XXX-2; xxxxxxxx-2 |
2-xxxxx-9-xxxxxx-4-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
||
Xxxxxxxx-X-xxxxx-xxxxxxx |
X-XXX; 2-Xxx-XXX, xxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
|
Xxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-1-xxxxxxx |
Xxxxxxxxxxxxx |
Xxxxxxxxxx |
2-xxxxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
Xx 5-3448 |
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx] xxxx |
|
Xxxxxxxxx |
XXX; 1,2-XXX; XXXX |
1-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
XX1X4X21 |
Xxxxxxxxxxxxx |
Xx 07-4065 |
7-xxxxx-5-(2,6-xxxxxxxxxxxx)-1-xxxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx |
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XX-4662 |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
|
Xxxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
3,4-xxxxxxxxxxxxxxx- xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
XXX |
X-[2-(xxxxx-3-xx)xxxxx]-X,X-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
2-(xxxxxxxxxxxxx)-3΄,4΄-(xxxxxxxxxxxxx)xxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-xxxxxx-1-xx |
|
XXXX-XXXXXXXX |
2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx xxxxxxxx |
||
XXX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(4-xxxxx-xxxxxxxx-1-xx)xxxxxxxx |
||
Xxxxxxxx |
XXXXX; xxxxxxxxxx; EPE |
N-ethyl-1,2-difenylethylamin |
|
EG-018 |
naftalen-1-yl(9-pentyl-9H-karbazol-3-yl)methanon |
||
EG-2201 |
(9-(5-fluorpentyl)-9H-karbazol-3-yl)(naftalen-1-yl)methanon |
||
EMB-FUBINACA |
Ethyl 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx |
||
Xxxxxxx |
XXXXX; xx-XXXX |
1-(xxxxx[x] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
X-xxxxx-xxxxxxxx |
Xxxxxxxxxxx |
Xxxxxxxxxxxx; X-xxxxxxxxxxxxxx; ETH-CAT |
2-ethylamino-1-fenyl-propan-1-on |
|
ETH-LAD |
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindo1-[4,3-fg]chinolin-9-karboxamid |
||
Ethylfenidát |
(RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát |
||
Ethylon |
bk-MDEA |
2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on |
|
Ethyltenamfetamin |
MDE, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxx |
XXX3219; Xxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-9-xxxxxx-67/-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
Xxxxxxx |
xx-XXXX, X-Xxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|
XXX-XX-22 |
1-xxxxxx 1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xxxxxxxxxx |
||
Xxxxxxx |
xxxxxxxx |
4-xxxxx-3-xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxxxxx |
Xx 11-5073/000 |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx -4X- [1,2,4]xxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
|
Xxxxxxxxxxxxx |
7-xxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxxx |
8-xxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxx-[4,3x] [1,4]benzodiazepin |
||
Fluklotizolam |
2-chlor-4-(2-fluorfenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]xxxxxxx[4,3-x] [1,4] xxxxxxxx |
||
Xxxxxxxxxxxxx |
6-(2-xxxxxxxxxx)-1-xxxxxx-8-xxxx-4X-[1,2,4]xxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxx |
Xx 05-4435 |
5-(2-xxxxxxxxxx)-1,3-xxxxxxx-7-xxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|
XXX-144 |
[1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XXX-XXX48 |
X-((3x,5x,7x)-xxxxxxxxx-1-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXX-018 |
(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-XXX-22 |
xxxxxxxx-8-x1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XX-22 |
xxxxxxxx-8-xx-1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
Xxxxxxxx |
β-xxxxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
Xxxxxxx |
βx-XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
|
XX-210 |
(6xX, 10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloktan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol |
||
HU-331 |
3S,4R-p-benzochinon-3-hydroxy-2-p-mentha-(1,8)-dien-3-yl-5-pentyl |
||
Hydroxytenamfetamin |
(2R,S)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
||
Indapyrofenidon |
1-(2,3-dihydro-1H-inden-5-yl)-2-fenyl-2-(pyrrolidin-1-yl)-ethanon |
||
Ioddimethoxyfenethylamin |
2C-I |
(4-iod-2,5-dimethoxyfenylethyl)amin |
|
Isohexedron |
4-methyl-2-(methylamino)-1-fenylpentan-1-on |
||
Isopropylfenidát |
IPPD |
isopropyl2-fenyl-2-(2-piperidyl)acetát |
|
JTE-907 |
N-(Benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydrochinolin-3-karboxamid |
||
JWH 018 X-5-xxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX 018 X-5-xxxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-007 |
1-xxxxxx-2-xxxxxx-3-(1-xxxxxxx)xxxxx |
||
XXX-018 |
(xxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-018 adamantoyl xxxxxxx; |
1-xxxxxx-3-(xxxxxxx-1-xxx)xxxxx |
||
XXX-018 xxxxxxxxxxxxxxx derivát |
[1-(cyklohexylmethyl)-1H-indol-3-yl] (naftalen-1-yl)methanon |
||
JWH-018 |
xxxxxxxx-8-xx-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-018 xxxxxxx xxxxxx |
1-xxxxxxxxxx(1-xxxxxx-1X-xxxxxxx-3-xx)-xxxxxxxx |
||
XXX-019 |
1-xxxxx-3-(1-xxxxxxx)xxxxx |
||
XXX-022 |
xxxxxxxx-1-xx(2-(xxxx-4-xxxx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-030 |
xxxxxxxx-1-xx(1-xxxxxx-1X-xxxxxx-3-xx)xxxxxxxx |
||
XXX-071 |
(1-xxxxx-1X-xxxxx-3-xx)-1-xxxxxxxxx 1-xxxxxxxx |
||
XXX-073 |
(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-073 xxxxxx xxxxxxx |
1-xxxxx-3-(1-(4-xxxxxx)xxxxxxx)xxxxx) |
||
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 xxxxxxxx 2-xxxxxxxxxxx xxxxxxx |
(4-xxxxxxxxxxxxxx-1-xx)(2-xxxxxx 1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 xxxxxxxx derivát |
(4-methylnaftalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-yl)methanon |
||
JWH-145 |
naftalen-1-yl(1-pentyl-5-fenyl-1H-pyrrol-3-yl)methanon |
||
JWH-182 |
1-pentyl-3-(4-propyl-1-naftoyl)indol |
||
JWH-200 |
[1-(2-morfolinoethyl)-1H-indol-3-yl] (xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-203 |
2-(2-xxxxxxxxxx)-1-(1-xxxxxxxxxxx-3-xx)xxxxxxx |
||
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
XXX-2501 2-xxxxxxxx-X-xxxxxx-xxxxxxxxx xxxxxxx |
1-(2-xxxxxxxx-X-xxxxxxxxxxxxxxx)-3-(2-xxxxxxxxxxxxxxxxxx)xxxxx |
||
XXX-251 |
2-(2-xxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-302 |
1-xxxxxx-3-(3-xxxxxxxxxxxxxxxxxx)xxxxx |
||
XXX-307 |
(5-(2-xxxxxxxxxx)-1-xxxxxxxxxxxx-3-xx)-xxxxxxxx-1-xxxxxxxxxx |
||
XXX-307 brom xxxxxxx |
(5-(2-xxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-368 |
[5-(3-xxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx |
||
XXX-370 |
[5-(2-xxxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx |
||
XXX-387 |
1-xxxxxx-3-(4-xxxx-1-xxxxxxx)xxxxx |
||
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-412 |
|||
XXX-412 5-xxxxxxxxxxx xxxxxxx |
(4-xxxxxxxxxxxxx-1-xx)[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx |
||
XXX-xxxxxxxxxxxxxxxx-8-xxxxxxxxxx; XX-22 |
xxxxxxxx-8-xx 1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
Xxxxxxxxxxxxx |
xxxxxxxxxx; BRN 4550445 |
8-xxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxx[4,3-x] [1,4]benzodiazepin |
|
Klonazolam |
6-(2-chlorfenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin |
||
Kloniprazepam |
5-(2-chlorfenyl)-1-(cyklopropylmethyl)-7-mtro-1,3-dihydro-2H-[1,4]-benzodiazepin-2-on |
||
LTI-701 |
1-(5-fluorpentyl)-N-fenyl-indol-3-karboxamid |
||
LY2183240 |
N,N-dimethyl-5-[(4-bifenyl)methyl]tetrazol-1-karboxamid |
||
M5FPIC |
methyl-1-(5-fluorpentyl)-1H-indol-karboxylát |
||
MAM-2201 |
1-(5-fluorpentyl)-3-(4-methyl-naftoyl)indol |
||
MAM-2201 xxxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](4-xxxxxx-xxxxxxxx-1-xx)-xxxxxxxx |
||
XXX-XXXXXXXX |
2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx xxxxxxxx |
||
XXXX |
1 -xxxxxx-4-xxxxxxxxxxxxxxx |
||
XXX 19 |
X-[(X)-(1-xxxxx-2-xxxxxxxx-3-xxxxxx)xxxxx]xxxxxxxx |
||
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
XXXX-4xx-XXXXXX |
(xxxxxx 3,3-xxxxxxxx-2-(1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxxxxx) butanoát) |
||
MDMB-FUBICA |
methyl 2-(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
XXXX-XXXXXXX |
xxxxxx 2-(9-(xxxxxxxxxxxxxxxx)-9X-xxxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
XXXX-XXXXXX |
X-[[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx]-3-xxxxxx-xxxxx, methyl xxxxx |
||
XXXX-XXXXX |
xxxxxx 3,3-xxxxxxxx-2-(9-xxxxxx-9 H-karbazol-3-karboxamido)butanoát |
||
MDPHP; 3,4-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
Xxxxxxxxxxxx |
(X)-5-(2-xxxxxxxxxx)-3-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
(4-xxxxxxxxxxxxxxx-1-xx)-(1-xxxxxxxxxxx-3-xx)xxxxxxxx |
||
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxx, Xxxxxxxxxxxxxxx |
2-xxxxxxxxxxxxx-1-xxxxxxxxxxx-1-xx |
|
Xxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxx, |
X-xxxxxx-1-(xxxxxxxx-2-xx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxx |
X-(2-xxxxxxx-xX-xxxxxxxxxxx)-5X,8X,11X,14X-xxxxxxxxxxxxxxxxx |
||
Xxxxxxxxx |
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
Xxxxxxxxxxxxxx |
XXXx, 2-Oxo-3'-methoxy-PCPr |
2-(3-methoxyfenyl)-2-(propylamino)cyklohexan-1-on |
|
Methoxyamfetamin |
PMA |
(2RS)-1-(4-methoxyfenyl)propan-2-amin |
|
Methoxymetamfetamin |
PMMA |
1-(4-methoxyfenyl)-N-methylpropan-2-amin |
|
Methoxytenamfetamin |
MMDA |
(2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin |
|
Methylaminorex |
(±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin |
||
Methylklonazepam |
ID 690; XX-690; methylclonazepam; Ro 05-4082; Xx 5-4082 |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx |
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2X,X)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
Xxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
Xxxxxxxx |
4-XXX-xXx; XXX |
(3-xxxxxxx-2-(xxxxxxxxxxx)-1-(x-xxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
X-XXXXX |
1-(xxxxxxxxxxxxxxxx)-2-xxxxxx-xxxxx-3-xxxxxxxxxx |
||
XX-18 |
X-(xxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXXXX |
1-xxxxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx 1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXxX-2201 |
xxxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxxx}-3-xxxxxxxxxxxxxx |
||
X-(2-xxxxxxxxxxxx)-X-(1-xxxxxxxxxxx)-2-(1-xxxxxx-1X-xxxxx-3-xx)-4-xxxxxxx-xxxxxxxxxx |
|||
X,X-xxxxxxx-2-(1-xxxxxx-1X-xxxxx-3-xx)-4-xxxxxxx-xxxxxxxxxx |
|||
Xxxxxxxxxxxxxxxxx |
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
X-2482 |
X-xxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxxxx, XXX |
2-(xxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
X-xxxxxxxxxxxxx |
xxxxx-xxxxxxxxx, xxxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxx, XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
XXX-xxxxx xxxxxx |
xx-XXX; , xx-XXXXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|
X-xxxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
X-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
|
X-xxxxxxxxxxxxx |
XXX-XX; Xxxxxxxxxxxxxx; Xxxxx-Xxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxx-1-xx |
|
X-xxxxx-xxxxxxxxxxx |
XXxX |
2-(xxxxxxxxxx)-4-xxxxxx-1-xxxxxxxxxxx-1-xx |
|
X-xxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
α-xxxxxxxxxxxxxxxxxx-xxx |
Xxxxxxxxx |
5-(2-xxxxxxxxxx)-3-xxxxxxx-7-xxxxx-1X-xxxxx[x][1,4]xxxxxxxx-2(3X)-xx |
||
X-xxxxxxxxxxxxxxxxx |
XxXX; X-xxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
X-xxxxxxxxxxxxxxxxxx |
XxXX; XXX, 2-IPP |
2-(isopropylamino)-1-fenylpentan-1-on |
|
Nitrazolam |
1-methyl-8-nitro-6-fenyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin |
||
NM-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
X-xxxxxx-2-xxxxxxxxxx |
X-xxxxxx-2XX |
2,3-xxxxxxx-X-xxxxxx-1X-xxxxx-2-xxxx |
XX-2XX |
X-xxxxxxxxxxxxxxx |
2-[xxxxxx(xxxxxx)xxxxx]-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxxxxx, xxxxxxxx-xxxxxxxxxx, xxxxxxxxxxxxx, Xx 5-3367 |
7-chlor-5-(2-fluorfenyl)-1,3-dihydro-1,4-benzodiazepin-2-on |
|
N-propylnorpentedron |
N-propylpentedron |
1-fenyl-2-(propylamino)pentan-1-on |
|
o-Acetylpsilocin |
4-AcO-DMT |
{3-[2-(dimethylamino)ethyl]-1H-indol-4-yl }acetát |
Psilacetin |
o-Desmethyltramadol |
ODT |
3-{-2-[(dimethylamino)methyl]-1-hydroxycyklohexyl}fenol |
|
Org 27569 |
5-xxxxx-3-xxxxx-X-{2-[4-(1-xxxxxxxxxxx)xxxxx]xxxxx}-1X-xxxxx-2-xxxxxxxxxx |
||
Xxx 27759 |
5-xxxxx-3-xxxxx-X-{2-[4-(xxxxxxxxxxxxx)xxxxx]xxxxx}-1X-xxxxx-2-xxxxxxxxxx |
||
Xxx 29647 |
5-xxxxx-3-xxxxx-X-(1-xxxxxxxxxxxxxxxx-3-xx)-3X-xxxxx-2-xxxxxxxxxx |
||
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
XX-22 xxxxxxx xxxxxx |
xxxxxxxx-8-xx-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxxxxx; βx-XXXX |
(±)-1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
x-Xxxxxx-4-xxxxxxxxxxxxxx |
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
x4-XXXX |
Xxxxxxxxxx |
XXX 48,098 |
(4-xxxxxxxxxxxx)-[2-xxxxxx-1-(2-xxxxxxxx-4-xxxxxxx)xxxxx-3-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxx; XX |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxx |
X-xxxxxxxxxxxxxxxxxx; |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
XX8, α-PHPP |
1 -xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
XX9, α-XXX |
1 -xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
||
Xxxxxxxxx |
8-xxxx-1-xxxxxx-6-(xxxxxxx-2-xx)-4X-[1,2,4]xxxxxxxx[4,3 -x] [1,4]benzodiazepin |
||
RCS-4 |
(4-methoxyfenyl)(l -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-4 xxxxx xxxxxx |
(2-xxxxxxxxxxxx)(x -pentyl-1H-indol-3-yl)methanon |
||
RCS-4(C4) |
4-methoxyfeny1-(1-butyl-1H-indol-3-yl)methanon |
||
Rolicyklidin |
PHP, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
Xxxxxxxxxx A |
methyl-(2RS,4aR,6aR,7R,9RS,10aRS,,10bR)-9-acetoxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxododekahydro-1H-benzo[f] isochromen-7-karboxylát |
||
SDB-005 |
naftalen-1-yl-1-pentyl-1H-indazol-3-karboxylát |
||
SDB-006 |
N-benzyl-1-pentyl-1H-indol-3-karboxamid |
||
SDB-006 X-xxxxx xxxxxx |
1-xxxxxx-X-xxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-135 |
X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
Xxxxxxxx |
xXxXXX; XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxx-xxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
Δ6x(10x)-, Δ6α(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-xxxxxxxxxxxxxxxxxxxx a xxxxxx xxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xxxxx |
||
XXX-2201 |
5X-XXX-018-X, |
[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx] (1 -xxxxxx)xxxxxxxx |
|
XX-XXX; 3',4'-xxxxxxxxxxxxxx-α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxx-2-xx)xxxxx-1-xx |
||
XX-XXX; 2-xxxxxxxxx-1-xx-1-xxxxxxxx-6-xx- xxxxx-1-xx |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxx-1-xx |
||
XX-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxxx-1-xx |
||
xxxxx-XX 47,497-X8 |
5-(1,1-xxxxxxxxxxxxx)-2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-xxxxx |
||
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
XX-144(-2X); |
[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
XX-144xxxxxx xxxxxxx |
(1-xxxxxx-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)-xxxxxxxx |
||
XX-144X-(5-xxxxxxxxxxx) xxxxxxx |
(1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XXX-597 |
[3-(3-xxxxxxxxxxxxxx)xxxxx]-X-xxxxxxxxxxxxxxxxxx |
||
XXX-754 |
6-xxxxxx-2-[(4-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxx-4-xx |
||
X-15 |
4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
X-18 |
4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
XXX 55212-2 |
(X)-(+)-[2,3-xxxxxxx-5-xxxxxx-3-(4-xxxxxxxxxxxxxxxx)xxxxxxx[1,2,3-xx]-1,4-xxxxxxxxxx-6-xxxxxxxxxxx-1-xxxxxxxxxx |
||
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxxx-1-xx |
||
α-Xxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxxxxxxx |
α-ΡιΗΡ |
1-xxxxx-4-xxxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxx |
α-XxxXX |
1-xxxxx-2-(xxxxxxxxx-1-xx)xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxx |
α-XXX; XX-10; xxxxx-xxxxxxxxx-xxxxxxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
β-Xxxx-xxxxxxxxxxxxxxxxxxxxxxxx |
xx-XXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx, xx xx xxxxxxxx výjimky, xxxxxxxxx x xxxxx xxxxxxx xx xxxxx xxxxxxxxx, kdy xxxx xxxxxxxxxxxxx mohou existovat xxxxx zvláštního xxxxxxxxxx xxxxxxxx, a solí x xxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx xx xxxxx případech, xxx xxxxx xxxxxxxxx.
Příloha č. 5 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 5 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) xxxxx]xxxxxxxxx |
||
Xxxxxxxxxx |
(2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx xxxxx-2-xx |
||
Xxxxxxxxxxxxxxxxxxxxx amin |
2C-B |
(4-brom-2,5-dimethoxyfenethyl)amin |
|
Dexamfetamin |
(2S)-1-fenylpropan-2-amin |
||
Fencyklidin |
PCP |
1-(1-fenylcyklohexyl)piperidin |
|
Fenetylin |
7-(2-{[(2RS)-1-fenylpropan-2-yl]amino}ethyl)-1,3-dimethyl-7H- xxxxx-2,6-xxxx |
||
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
XXX |
xxxxxxxx 4-xxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxx | (2X)-2,6-xxxxxxx-X-[(2X)-1-xxxxxxxxxxx-2-xx]xxxxxxxxx | ||
Xxxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-xxxxxx-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
Xxxxxxxxxx |
2-xxxxxxx-3-(2-xxxxxxxxxxx)-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
Xxxxxxxxxxxx |
(2X)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxx xxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxx |
xxxxxx-(2XX)-2-xxxxx-2-[(2XX)-xxxxxxxxx-2-xx]xxxxxx |
||
Xxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxx stereoizomery x xxxxxx |
xxxx. (-)-xxxxx-Δ9-XXX |
Xxxxxxxx |
(2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] xxxxxx-2xx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx všech případech, xxx xxxxxxxxx xxxxxxxx xxxx xx možná.
Příloha x. 6 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 6 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxx |
xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxxx | XXX | xxxxxx-2-xx | xxxxx-xxxxxxxxxxxxx |
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- hexahydro-2,6-methano-3-benzazocin-8-ol |
||
Pentobarbital |
kyselina 5-xxxxx-5[(1XX)-1-xxxxxxxxxxx]xxxxxxxxxxx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx skupině xx xxxxx případech, xxx xxxxxxxxx xxxxxxxx xxxx je xxxxx.
Příloha x. 7 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 7 psychotropních xxxxx
Xxxxxxxxxxx xxxxxxxxxx název (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx kyselina |
||
Alprazolam |
8-chlor-6-fenyl-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin |
||
Amfepramon |
2-(diethylamino)-1-fenylpropan-1-on |
||
Aminorex |
5-fenyl-4,5-dihydrooxazol-2-amin |
||
Barbital |
5,5-diethylbarbiturová xxxxxxxx |
||
Xxxxxxxxxx |
XX 718; QM 6008; Xxxxxxxxxx; |
5-xxxxx-1,3,6,7,8,9-xxxxxxxxx-2X-[1]xxxxxxxxxxx[2,3-x] [1,4]diazepin-2-on |
|
Benzfetamin |
(+)-N-benzyl-N-(2-fenyl-1-methylethy)-N-methylamin |
||
Benzylpiperazin |
1-benzylpiperazin |
||
Bromazepam |
7-brom-5-(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Brotizolam |
2-brom-4-(2-chlorfenyl)-9-methyl-6H-thieno[3,2-ƒ][1,2,4]triazolo[4,3-a][1,4]diazepin |
||
Butobarbital |
5-butyl-5-ethylbarbiturová kyselina |
||
Cinazepam |
BD-798; |
4-[[7-brom-5-(2-chlorfenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]oxy]-4-oxo-butanová xxxxxxxx |
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx)xxxxxxxx |
||
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxx |
7-Xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx kyselina |
||
Fenproporex |
(+)-1-fenyl-2-[(2-kyanethyl)amino] xxxxxx |
||
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-2-[2-(xxxxxxxxxxxx)xxxxx]-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
XX-xxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
XX-xxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxxxxxxxxxx |
||
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-4,7(6X)-xxxx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxxx-2,4(3X,5X)-xxxx |
||
Xxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X-xxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2.1-α]-xxxxxxxx-5-xx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx kyselina |
||
Methyprylon |
3,3-diethyl-5-methylpiperidin-2,4-dion |
||
Midazolam |
8-chlor-6-(2-fluorfenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin |
||
Nimetazepam |
5-fenyl-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Nitrazepam |
5-fenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Nordazepam |
7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Oxazepam |
7-chlor-5-fenyl-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Oxazolam |
10-chlor-11b-fenyl-2-methyl-2,3,7,11b-tetrahydrooxazolo[3,2-d] [1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxx |
5-xxxxx-2-xxxxx-1,3-xxxxxxxxxx-4-xx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(xxxx-2-xx-1-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
xxxxxxx(2-xxxxxxxxx)xxxxxxxx |
||
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxx |
(+)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx | Xxxxxxxxx, Emandaxin, XXXX 341 Nodeprine, Xxxxxx, XX | 1-(3,4-xxxxxxxxxxxxxx)-5-xxxxx-7,8-xxxxxxxxx-4-xxxxxx-5X-2,3-xxxxxxxxxxxxx | |
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx kyselina |
||
Zolpidem |
N,N,6-trimethyl-2-(4-methylfenyl)imidazo[1,2-a]pyridin-3-acetamid |
Včetně solí xxxxxxxxxxxxxx látek uvedených x&xxxx;xxxxx seznamu ve xxxxx případech, kdy xxxx soli xxxxx xxxxxxxxx.
Příloha x. 8 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 8 xxxxxxxxx xxxxxxxxx
Xxxxxxxxx obsahující: |
Podmínky: |
||
1) |
jednu x xxxxxxxx látek: acetyldihydrokodein dihydrokodein ethyImorfin folkodin kodein nikodikodin nikokodin norkodein |
Mohou xxxxxxxxx xxxxx nebo více xxxxxxx xxxxx (nikoliv xxxx xxxxxxxx) x xxxxxxxx omamné xxxxx |
|
x) |
x xxxxx tabletě, xxxxxxx, xxxxxx, čípku, xxxx. x xxxx xxxxxx xxxxx xxxxx xxxxxxxxxx 100 xx, |
||
x) |
x xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 2,5 % |
||
2) |
xxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxx xxxxx xxxxxxxxxx v jedné xxxxxxx, tobolce, ampuli, xxxxx, xxxx. x xxxx xxxxxx xxxxx 0,5 xx. |
x) |
Xxxxxxxx atropin-sulfátu xxxx xxx xxxxxxx 5 % k xxxxxxxx xxxxxxxxxxxx v xxxxx xxxxxxx, xxxxxx, xxxxxx, xxxxx, popř. xxxx xxxxxx xxxxx. |
||
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, ampuli, čípku, xxxx. x jiné xxxxxx xxxxx 2,5 xx. |
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx xxxxxxx 1 % x xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, ampuli, xxxxx, popř. x xxxx lékové xxxxx. |
||
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
x) |
xxxxx xxxxxxxxxx 135 xx x xxxxx xxxxxxx, tobolce, xxxxxx, xxxxx, příp. v xxxx lékové xxxxx. |
||
x) |
x xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 2,5 %. |
||
Xxxxxxxxx xxxxx xxxxxxxxx žádnou xxxxxxxxxxxx xxxxx. |
|||
5) |
xxxxxx |
Xxxxxxxx kokainu nesmí xxxxxxxxxx 0,1 % xxxxxxx. |
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,2 %. |
x) |
Xxxx xxxxx xxxxxxxxx xxxxx nebo xxxx xxxxxxx xxxxx (xxxxxxx xxxx omamných). |
||
Omamná xxxxx v xxxxxxxxx xxxxxxxx nesmí být xxxxxx xxxxxxx xxxx x xxxxxxx množství, xxx xxxxxxxx veřejné xxxxxx |
|||
7) |
xxxxxxxxxxxxx xxxxxx s xxxxx |
x) |
Xxxxxxxx xxxx v xxxxxx xxxxx xxx xxxxx než 10 %. |
x) |
Xxxxxxxx xxxxxxxxxxxxxxx xxxxxx xxxxx být vyšší xxx 10 %. |
||
c} |
Množství xxxxx nebo xxxx xxxxxxx xxxxx (nikoliv xxxx xxxxxxxxx) xxxxx xxx xxxxx xxx 80%. |
||
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx propiramu xxxxx xxxxxxxxxx 100 xx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v jiné Xxxxxx xxxxx. |
x) |
Xxxxxxxxx xxxxxxxxxxxxxx x přípravku xxxx xxx nejméně xxxxxx xxxx vyšší xxx xxxxxxxxx. |
Xxxxxx xxxxxxxxxxxx vyrobených xxxxxxxxx, xxxxxxx xxxxxx xxxxxx je vyšší xxx D4 xxxx XX2.
Xx. II
Toto xxxxxxxx xxxx xxxxxxxx x xxxxxxx se směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx při poskytování xxxxxxxxx v xxxxxxx xxxxxxxxxxx předpisů a xxxxxxxx pro služby xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 46/2017 Sb. x xxxxxxxxx xx 1.3.2017
Čl. XX
Xxxx nařízení xxxx xxxxxxxx x xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx xxx služby xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx právním předpisem x. 30/2018 Sb. x xxxxxxxxx od 8.3.2018
Xx. XX
Xxxx nařízení xxxx oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx při poskytování xxxxxxxxx x oblasti xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 242/2018 Sb. x účinností od 25.10.2018
Xx. XX
Xxxxxxxxx předpis
Toto xxxxxxxx xxxx oznámeno x xxxxxxx se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Rady (XX) 2015/1535 ze xxx 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx informací x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx právním xxxxxxxxx x. 184/2021 Xx. x xxxxxxxxx xx 3.6.2021
Xx. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Rady (XX) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx technických xxxxxxxx x předpisů xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX vložen právním xxxxxxxxx x. 159/2022 Xx. s xxxxxxxxx xx 1.7.2022
Čl. II
Technický předpis
Toto xxxxxxxx xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Evropského parlamentu x Xxxx (XX) 2015/1535 ze dne 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx informací v xxxxxxx xxxxxxxxxxx předpisů x předpisů pro xxxxxx informační xxxxxxxxxxx.
Xx. XX vložen xxxxxxx xxxxxxxxx x. 228/2023 Xx. x účinností xx 1.8.2023
Xx. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x předpisů xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx č. 52/2024 Xx. x xxxxxxxxx xx 6.3.2024
Čl. II
Technický xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (XX) 2015/1535 ze dne 9. září 2015 x postupu xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x předpisů pro xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 176/2024 Xx. x xxxxxxxxx xx 1.7.2024
Xx. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx bylo oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Rady (XX) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx v xxxxxxx technických xxxxxxxx x předpisů xxx xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx č. 419/2024 Xx. x xxxxxxxxx xx 1.1.2025
Xxxxxx předpis x. 463/2013 Sb. nabyl xxxxxxxxx dnem 1.1.2014.
Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx xxxx xxxxxxxxxx xxxxx a xxxxxxxx xxxxxxxxxxx xxxxxxx předpisem x.:
243/2015 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx
x účinností xx 1.10.2015
46/2017 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx znění nařízení xxxxx č. 243/2015 Xx.
x účinností xx 1.3.2017 x xxxxxxxx xxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., xxxxxx xx xxxx nařízení vlády x. 463/2013 Xx., x seznamech xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 8.3.2018
242/2018 Sb., xxxxxx se xxxx xxxxxxxx xxxxx č. 463/2013 Sb., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 25.10.2018
184/2021 Sb., kterým xx xxxx xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 3.6.2021
159/2022 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.7.2022
228/2023 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx od 1.8.2023
52/2024 Sb., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx se xxxx xxxxxxxx vlády č. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.7.2024 x 1.1.2025
419/2024 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.1.2025 a 1.4.2025
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx jiných právních xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.
1) Xxxxxxxx úmluva x xxxxxxxx xxxxxxx, xxxxxxxxx xxx č. 47/1965 Sb., xx xxxxx Xxxxxxxxx x xxxxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
Xxxxxxxx Komise x xxxxxxxxx xxxxxxxxx (XX) 2022/1326 ze xxx 18. xxxxxx 2022, xxxxxx xx mění xxxxxxx rámcového xxxxxxxxxx Xxxx 2004/757/XXX, xxxxx xxx x zahrnutí xxxxxx psychoaktivních xxxxx xx xxxxxxxx drogy.
2) Xxxxxx x xxxxxxxxxxxxxx xxxxxxx, vyhlášená xxx č. 62/1989 Sb.
3) Rámcové xxxxxxxxxx Xxxx 2004/757/SVV ze xxx 25. xxxxx 2004, kterým se xxxxxxx xxxxxxxxx ustanovení xxxxxxxx xx xxxxx xxxxxxxxxx xxxxxxx trestných xxxx x xxxxxx x oblasti nedovoleného xxxxxxx s xxxxxxx.
Xxxxxxxx Xxxxxxxxxx parlamentu a Xxxx (EU) 2017/2103 xx xxx 15. xxxxxxxxx 2017, xxxxxx xx xxxx xxxxxxx xxxxxxxxxx Xxxx 2004/757/SVV x xxxxx xxxxxxxx xx definice drogy xxxx xxxxxxxxxxxxx látky x xxxxxxx rozhodnutí Xxxx 2005/387/XXX.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (XX) 2019/369 ze xxx 13. prosince 2018, xxxxxx xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX, xxxxx xxx x xxxxxxxx nových psychoaktivních xxxxx do xxxxxxxx xxxxx.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (XX) 2020/1687 xx xxx 2. září 2020, xxxxxx xx mění xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX, xxxxx xxx o zahrnutí xxxx xxxxxxxxxxxxx xxxxx X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1 H-benzimidazol-1-ethanamin (xxxxxxxxxxxx) xx definice drogy.
Směrnice Xxxxxx x xxxxxxxxx xxxxxxxxx (EU) 2021/802 xx dne 12. xxxxxx 2021, xxxxxx xx xxxx xxxxxxx xxxxxxxxx rozhodnutí Rady 2004/757/XXX, pokud jde x xxxxxxxx xxxxxx xxxxxxxxxxxxxxx látek methyl 3,3-xxxxxxxx-2-{[1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx} xxxxxxxx (MDMB-4en-PINACA) x xxxxxx 2-{[1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx (4X-XXXX-XXXX) xx xxxxxxxx xxxxx.